stella
beta
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI) — Stella
Home
/
Pancreatic Cancer
/
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
View on ClinicalTrials.gov
Recruiting
Back to Pancreatic Cancer trials
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Trial locations
(1 site)
China
Shanghai Changhai Hospital, Shanghai